Evotec (UK) Ltd
Dr. Alexander Heifetz is Principal Scientist at Evotec (UK) Ltd, a drug discovery services company and visiting scientist at University College London at the group of Prof Andrea Townsend-Nicholson. Alex has more than 15 years of experience in drug discovery industry and was involved in discovery of 4 clinical drug candidates for treatment of anxiety, major depressive disorder, pulmonary hypertension, and Alzheimer’s disease. He has more than 35 patents and 40 publications in the area of medicinal chemistry. In 2011 he received the Royal Society Industry Award for development of methods for GPCR modeling. In 2001 he obtained his PhD from the Weizmann Institute of Science.
Materials Chemistry including Nanomaterials Materials Chemistry Nanoscience & Technology Medicinal Chemistry Electrochemistry Applied research in nanomaterials/ Process Development/Engineering Drug Design and Virtual Screening Controlled Drug Delivery Systems